Home Actavis Beats Q3 Views As Buyout Talk Swirls
 

Keywords :   


Actavis Beats Q3 Views As Buyout Talk Swirls

2014-11-06 05:57:54| Biotech - Topix.net

Generic and specialty drug giant Actavis beat Wall Street's third-quarter estimates and raised its guidance early Wednesday, sending the stock to a new high of 254.41 before closing up 1.1% at 247.91. ' earnings, excluding one-time items, rose 53% over the year-earlier quarter to $3.19 a share, beating analysts' consensus by 9 cents, according to Thomson Reuters.

Tags: views talk beats buyout

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
04.11Tropical Depression Eighteen Graphics
04.11Summary for Tropical Depression Eighteen (AT3/AL182024)
04.11Tropical Depression Eighteen Public Advisory Number 4A
04.11Telekom Srbija renews satellite services contract with SES
04.11Remnants of Patty Graphics
04.11Charter video customers down 294,000 in 3Q 2024
04.11Atlantic Tropical Weather Outlook
04.11Eastern North Pacific Tropical Weather Outlook
More »